Drugs / IOV-2001
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04155710 | Feb 2020 → Nov 2024 | chronic lymphocytic leukemia/small lymphocytic lymphoma | Iovance Biotherapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IOV-2001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04155710 ↗ |
| Modality | Cell therapy | “IOV-2001 (Adoptive Cell Therapy)” NCT04155710 ↗ |